(2026). B7-H3 (CD276) as Target for T Cell-Based Bispecific Antibody Therapy of Penile Cancer. ImmunoTargets and Therapy.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"B7-H3 (CD276) as Target for T Cell-Based Bispecific Antibody Therapy of Penile Cancer."
ImmunoTargets and Therapy 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"B7-H3 (CD276) as Target for T Cell-Based Bispecific Antibody Therapy of Penile Cancer."
ImmunoTargets and Therapy, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.